GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » RPG Life Sciences Ltd (NSE:RPGLIFE) » Definitions » Cyclically Adjusted PB Ratio

RPG Life Sciences (NSE:RPGLIFE) Cyclically Adjusted PB Ratio : 13.07 (As of Jun. 04, 2025)


View and export this data going back to 2008. Start your Free Trial

What is RPG Life Sciences Cyclically Adjusted PB Ratio?

As of today (2025-06-04), RPG Life Sciences's current share price is ₹2165.20. RPG Life Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₹165.68. RPG Life Sciences's Cyclically Adjusted PB Ratio for today is 13.07.

The historical rank and industry rank for RPG Life Sciences's Cyclically Adjusted PB Ratio or its related term are showing as below:

NSE:RPGLIFE' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 3.36   Med: 6.42   Max: 17.98
Current: 13.17

During the past years, RPG Life Sciences's highest Cyclically Adjusted PB Ratio was 17.98. The lowest was 3.36. And the median was 6.42.

NSE:RPGLIFE's Cyclically Adjusted PB Ratio is ranked worse than
95.11% of 696 companies
in the Drug Manufacturers industry
Industry Median: 1.975 vs NSE:RPGLIFE: 13.17

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

RPG Life Sciences's adjusted book value per share data for the three months ended in Mar. 2025 was ₹320.775. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹165.68 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


RPG Life Sciences Cyclically Adjusted PB Ratio Historical Data

The historical data trend for RPG Life Sciences's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RPG Life Sciences Cyclically Adjusted PB Ratio Chart

RPG Life Sciences Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.67 4.69 5.31 10.48 13.77

RPG Life Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.48 - 15.08 - 13.77

Competitive Comparison of RPG Life Sciences's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, RPG Life Sciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RPG Life Sciences's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, RPG Life Sciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where RPG Life Sciences's Cyclically Adjusted PB Ratio falls into.


;
;

RPG Life Sciences Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

RPG Life Sciences's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2165.20/165.68
=13.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RPG Life Sciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, RPG Life Sciences's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=320.775/157.5517*157.5517
=320.775

Current CPI (Mar. 2025) = 157.5517.

RPG Life Sciences Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.000 99.841 0.000
201509 78.532 101.753 121.597
201512 0.000 102.901 0.000
201603 76.560 102.518 117.659
201606 0.000 105.961 0.000
201609 92.938 105.961 138.188
201612 0.000 105.196 0.000
201703 88.887 105.196 133.126
201706 0.000 107.109 0.000
201709 87.369 109.021 126.261
201712 0.000 109.404 0.000
201803 93.567 109.786 134.276
201806 0.000 111.317 0.000
201809 93.035 115.142 127.302
201812 0.000 115.142 0.000
201903 97.043 118.202 129.349
201906 0.000 120.880 0.000
201909 105.018 123.175 134.327
201912 0.000 126.235 0.000
202003 106.760 124.705 134.880
202006 0.000 127.000 0.000
202009 118.925 130.118 143.999
202012 0.000 130.889 0.000
202103 130.872 131.771 156.477
202106 0.000 134.084 0.000
202109 141.369 135.847 163.956
202112 0.000 138.161 0.000
202203 154.647 138.822 175.512
202206 0.000 142.347 0.000
202209 168.051 144.661 183.026
202212 0.000 145.763 0.000
202303 185.985 146.865 199.519
202306 0.000 150.280 0.000
202309 202.999 151.492 211.119
202312 0.000 152.924 0.000
202403 226.646 153.035 233.336
202406 0.000 155.789 0.000
202409 229.385 157.882 228.905
202412 0.000 158.323 0.000
202503 320.775 157.552 320.775

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


RPG Life Sciences  (NSE:RPGLIFE) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


RPG Life Sciences Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of RPG Life Sciences's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


RPG Life Sciences Business Description

Traded in Other Exchanges
Address
463, Dr. Annie Besant Road, RPG House, Near Old Passport Office, Worli, Mumbai, MH, IND, 400030
RPG Life Sciences Ltd is an integrated pharmaceutical company. Its only reportable segment is the manufacturing and marketing of pharmaceutical products. Geographically, it derives a majority of revenue from India. The company operates across Domestic Formulations, International Formulations and Active Pharmaceutical Ingredients (API). It focuses on Nephrology, Oncology, Urology, Respiratory, Gastrointestinal, Cardiovascular, Gynaecology and Pediatrics, Vitamins and Minerals, Pain Management, Neurology, Anti-Dengue, Anti-Diabetic, and Derma.

RPG Life Sciences Headlines

No Headlines